| Discover a treatment option for sudden bleeds. |
View online |
|
|
|
|
|
 |
| NovoSeven® RT is used to treat bleeding episodes in people with hemophilia A or B with inhibitors, congenital Factor VII deficiency, Glanzmann’s thrombasthenia with resistance to platelets, and acquired hemophilia. |
|
|
|
|
When bleeds happen,
will you be prepared? |
|
|
 |
| Bob lives with hemophilia A with inhibitors. |
| For more than 30 years, people with hemophilia A with inhibitors have trusted NovoSeven® RT to control bleeds.a,b Indicated for people of all ages,c it's approved for use before, during, and after surgery and procedures. |
| And it has a proven safety profile when used with Hemlibra. |
| aFor people with hemophilia A or B with inhibitors. |
| bCompassionate use, also known as expanded access, began enrolling in 1988; FDA approval received in 1999. |
| cIn people with acquired hemophilia, NovoSeven® RT is only indicated for adults. |
|
|
|
Selected Important Safety Information
|
|
What is the most important information I should know about NovoSeven® RT?
|
|
NovoSeven® RT may cause serious side effects, including:
|
| • |
Serious blood clots that form in veins and arteries with the use of
NovoSeven® RT have been reported
|
|
| • |
Your healthcare provider should discuss the risks and explain the signs and symptoms
of blood clots to you. Some signs of a blood clot may include pain, swelling,
warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or
sudden severe headache and/or loss of consciousness or function
|
|
| • |
Your healthcare provider should monitor you for blood clots during treatment with
NovoSeven® RT
|
|
| Please click here or scroll below for additional Important Safety Information. |
|
|
|
 |
| An established safety profile that comes from experience.b |
| NovoSeven® RT is designed with your safety in mind. It has a proven safety profile when used with Hemlibra if you have hemophilia A with inhibitors. Studies also show it has a low rate of thrombotic adverse events (blood clots).d |
|
|
| dThe most common and serious side effects are blood clots. |
|
|
One-to-one support,
every step of the way. |
| Novo Nordisk Hemophilia Community Liaisons—known as HCLs—are available to answer your questions about NovoSeven® RT. Experienced and active in the hemophilia community, HCLs can provide you with resources to help manage your bleeding disorder. |
|
|
|
|
| What is NovoSeven® RT? |
| NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for: |
| • |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions |
|
| • |
Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia |
|
| Important Safety Information (cont’d) |
| • |
You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness |
|
| What should I tell my healthcare provider before using NovoSeven® RT? |
| • |
Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots: |
| |
| ◦ |
congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates) |
| ◦ |
are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding |
| ◦ |
history of heart or blood vessel diseases |
|
| • |
Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies |
|
| What are the possible side effects of NovoSeven® RT? |
| • |
The most common and serious side effects are blood clots |
|
| • |
Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction |
|
| Please click here for Prescribing Information. |
| NovoSeven® RT is a prescription medication. |
| You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. |
|
|
|
| PLEASE DO NOT RESPOND TO THIS EMAIL. If you would like to contact us, please click here or call 1‑877‑744‑2579. |
| UNSUBSCRIBE NOTICE |
| If you no longer want to receive communications from Novo Nordisk, click here to unsubscribe. You also may call us at 1-877-744-2579 or send us a letter that includes your full contact information (e.g. name, email address, phone) to Novo Nordisk, 800 Scudders Mill Road, Plainsboro, New Jersey 08536. To better understand how Novo Nordisk values your privacy, see our Privacy Statement. |
|
NovoSeven® is a registered trademark of Novo Nordisk Health Care AG.
All other trademarks, registered or unregistered, are the property of their respective owners.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2022 Novo Nordisk All rights reserved. US22NSVN00012 May 2022 |
 |
|
|
|
